O'Shaughnessy Asset Management, LLC Exelixis, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $2,296 - $3,172	-145 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$16.3 - $21.14 $782 - $1,014	48 Added 49.48%	145 $3,000
Q2 2021 Aug 09, 2021	SELL	$17.95 - $25.56 $1,400 - $1,993	-78 Reduced 44.57%	97 $2,000
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $1,231 - $1,513	60 Added 52.17%	175 $4,000
Q4 2020 Feb 11, 2021	SELL	$18.39 - $24.8 $37,938 - $51,162	-2,063 Reduced 94.72%	115 $2,000
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $5,787 - $7,543	-280 Reduced 11.39%	2,178 $53,000
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $40,458 - $67,398	2,458 New	2,458 $58,000

460

240M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.53B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.